Trivitron Healthcare and IFHA Launch an Innovative New Medical Technology Joint Venture Focused on the African Continent

Dubai, UAE. January 30, 2018 – Trivitron Healthcare Private Limited (“Trivitron”), India’s leading medical technology company, together with the Investment Funds for Health in Africa (“IFHA”), a leading private equity investor in the healthcare sector in Africa, are excited to announce the launch of Trivitron Healthcare Africa B.V. (“THA”), a new medical technology company focused on the African continent. THA will provide high-quality medical devices and instruments with reliable after-sales service support across Africa, thereby improving access and affordability of medical equipment across the continent.

In its first phase of operations, Trivitron Healthcare Africa will be headquartered in Dubai, United Arab Emirates, with a direct presence and sales and service infrastructure in four major hubs: Nairobi, Kenya; Johannesburg, South Africa; Lagos, Nigeria and Algiers, Algeria. The company will leverage these hubs to support neighboring countries and manage an extensive channel partner network across the African continent.

THA’s initial offering will include a complete range of products and after-sales service support in laboratory medicine, medical imaging, critical care, operating room and renal care. The company will not only distribute and support products manufactured by Trivitron in their nine USFDA, CE certified factories in India, Finland, and Turkey; but it will also distribute and support products from other leading multinational corporations.

In addition, THA will have an exclusive Projects division capable of executing turnkey hospital projects in the African continent. THA is already working with a leading healthcare group in East Africa to support the design and equipping of its new flagship hospital in Nairobi, Kenya. The company will also have a Multi-Vendor Biomedical Engineering Services division to ensure support for healthcare providers across Africa, and focus on academic initiatives, offering paramedical and super specialty support courses in association with reputed academic institutions from India and Europe.

THA is in advanced discussions with the International Finance Corporation (“IFC”), a member of the World Bank Group and investor in many of the leading healthcare providers in Sub-Saharan Africa, for a debt investment to support its growth strategy.

Dr. GSK Velu, Chairman and Managing Director of Trivitron said, “This is a first of its kind venture between the leading medical technology company in India and a leading healthcare private equity investor in Africa, with support from IFC.”

“IFHA has long seen an opportunity to improve access to quality healthcare services by creating a provider of high-quality, affordable medical equipment and services. IFHA is excited to partner with Trivitron and IFC to turn this vision into a reality.” said Max Coppoolse, the Managing Partner of IFHA.

About Trivitron

Since 1997, the journey of Trivitron Healthcare as a medical technology company providing affordable healthcare solutions weaves a fascinating thread of inspiration to many healthcare providers. Trivitron markets its products to hospitals, individual healthcare providers, independent clinics and laboratories, extended care facilities and all other roofs providing healthcare solutions. As a pioneer in the field, Trivitron constantly pursues technological innovations to offer superior clinical benefits at a lower cost. At Trivitron, quality healthcare is considered as a fundamental right and the vision is to make it available for the people of all classes.

Having a solid expertise in research and development, Trivitron manufactures and distributes exceptional medical technology products to 165 countries. A family of 1,500+ employees and the support of 1,200+ channel partners prepare the organization for unexpected challenges and aligns the company’s daily activities with its vision. With 9 USFDA, CE certified manufacturing facilities, supported by several R&D tie-ups with global leaders, Trivitron holds the record of 50,000+ installations across the globe. Today, Trivitron spearheads innovation in the fields of Newborn Screening, In-Vitro Diagnostics, Imaging & Radiology, Radiation Protection, Critical Care, Renal Care and Operating Room Solutions, thus, engraving its name as a holistic healthcare provider.

About IFHA

When it was launched in 2008 in Amsterdam, Netherlands, the Investment Funds for Health in Africa (IFHA) was the first private equity fund dedicated to investing in small and medium enterprises in the private healthcare sector in Africa. Today, IFHA manages two funds with approximately $200 million of assets under management, focusing its investments across various healthcare segments including healthcare provision, health insurance, health management organizations, administration providers, purchasing companies, medical asset financing, pharmaceutical production and distribution, medical equipment distribution and medical education. After nearly 10 years of operations, IFHA builds on its strong network and a solid track record of results from its first round investees, which include six successful exits.

For further information, please contact:

Mr. Amit Arora, Corporate Communication, Trivitron at

Mr. Shayne Aman Premji, Director, IFHA at

Hygeia Nigeria Limited Acquires Gold Cross Hospital

Hygeia Nigeria Limited – Press Release (March 2017)

Lagoon Hospitals acquires Gold Cross Hospital

Lagos, Nigeria, March 7, 2017: Hygeia Nigeria Limited (“HNL”) has today announced the acquisition of Gold Cross Hospital (GCH), a 35 bedded multi-disciplinary, tertiary care hospital located at Bourdillon Ikoyi, Lagos, subject to regulatory approval. The acquisition also includes Gold Cross MRI Diagnostics located in Ikeja, a fully operational diagnostic centre with MRI, CT Scan and other diagnostics facilities.

This move is in line with Lagoon Hospital’s ambitious growth strategy and will bring its clinical and management experience and expertise in the operations of Gold Cross Hospital.

Lagoon Hospitals, part of Hygeia Group, is planning to develop Gold Cross Hospital as a multispecialist centre catering to secondary and tertiary care across various specialties not limited to
maternal and child health, Orthopaedics and Trauma, General and Minimal Access Surgery, emergency medicine and Cardiac Sciences. Senior clinicians from the Lagoon Hospital network will
augment the existing medical resource pool.

Established in 1989, Gold Cross Hospital over the last 25 years has risen to become one of the leading private medical facilities in Nigeria. Accredited by National Health Insurance Scheme, the hospital is a well-known medical centre offering quality clinical care services.

“This development is part of our ongoing expansion strategy. We are executing on this growth strategy by adding to our capacity. This development is coming soon after the recent expansion of
the Ikeja facility from 22 to 40 beds and upgrading of medical equipment, including addition of state-of –the-art diagnostic equipment. We believe that we will be able to integrate Gold Cross Hospital with our other hospitals fairly quickly to optimize clinical and service standards,” said Mr Max Coppoolse, Chairman of HNL, The founder of Gold Cross Hospital, Dr Ladi Okuboyejo said “This recently concluded integration of Gold Cross Hospital Bourdillon in Ikoyi and MRI Centre in Ikeja with the Hygeia Group is set to transform Nigeria into a hub for medical tourism in West Africa. It’s a step in the right direction for emergence of private multi specialist hospitals which will stem the tide for the need to seek medical treatment abroad considering the exchange rate of the dollar. For me personally, it’s a dream come true to leave a legacy that will outlive the founders”